Diamante Turri

830 total citations
8 papers, 97 citations indexed

About

Diamante Turri is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Diamante Turri has authored 8 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Genetics and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Diamante Turri's work include Chronic Myeloid Leukemia Treatments (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Diamante Turri is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Diamante Turri collaborates with scholars based in Italy. Diamante Turri's co-authors include Roberto Perricone, Vincenzo Bàrbera, Matteo Rosselli, Mario Cottone, Paolo Simioni, Giuliano Mariani, Giuseppe Martorana, Stefania Grimaudo, Guglielmo Mariani and Ada Maria Florena and has published in prestigious journals such as Blood, Digestive and Liver Disease and Annals of Hematology.

In The Last Decade

Diamante Turri

8 papers receiving 94 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diamante Turri Italy 5 59 49 28 18 15 8 97
Daniela Bartoletti Italy 6 65 1.1× 38 0.8× 26 0.9× 8 0.4× 6 0.4× 10 111
Feras Alfraih Saudi Arabia 8 63 1.1× 40 0.8× 8 0.3× 17 0.9× 24 1.6× 25 141
N. Pollicardo Italy 9 218 3.7× 108 2.2× 46 1.6× 19 1.1× 28 1.9× 15 237
Luis Meillón Mexico 5 93 1.6× 55 1.1× 48 1.7× 7 0.4× 15 1.0× 15 111
Kento Umino Japan 8 65 1.1× 32 0.7× 21 0.8× 41 2.3× 31 2.1× 23 148
Asu Fergün Yılmaz Türkiye 5 103 1.7× 40 0.8× 8 0.3× 22 1.2× 32 2.1× 20 147
Thomas Noesslinger Austria 4 31 0.5× 24 0.5× 19 0.7× 18 1.0× 17 1.1× 15 79
Roberta Murru Italy 6 50 0.8× 73 1.5× 5 0.2× 32 1.8× 23 1.5× 12 133
J. Séguier France 6 32 0.5× 20 0.4× 37 1.3× 26 1.4× 16 1.1× 19 114
Tuulikki Sokka‐Isler Finland 7 38 0.6× 39 0.8× 84 3.0× 32 1.8× 15 1.0× 17 157

Countries citing papers authored by Diamante Turri

Since Specialization
Citations

This map shows the geographic impact of Diamante Turri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diamante Turri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diamante Turri more than expected).

Fields of papers citing papers by Diamante Turri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diamante Turri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diamante Turri. The network helps show where Diamante Turri may publish in the future.

Co-authorship network of co-authors of Diamante Turri

This figure shows the co-authorship network connecting the top 25 collaborators of Diamante Turri. A scholar is included among the top collaborators of Diamante Turri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diamante Turri. Diamante Turri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Efficace, Fabio, Gianantonio Rosti, Massimo Breccia, et al.. (2015). The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia. Annals of Hematology. 95(2). 211–219. 15 indexed citations
2.
Malato, Alessandra, et al.. (2013). Successful Salvage Treatment With Clofarabine and Cytarabine In Relapsed/Refractory Acute Myeloid Leukemia. Blood. 122(21). 5039–5039. 1 indexed citations
3.
Rossi, Antonella Russo, Massimo Breccia, Fausto Castagnetti, et al.. (2010). Outcome of Patients with CML Treated with Dasatinib or Nilotinib after Failure of Second Prior TKIs. Blood. 116(21). 2294–2294. 2 indexed citations
4.
Vigneri, Paolo, Fabio Stagno, Stefania Stella, et al.. (2010). BCR-ABLIS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.. Blood. 116(21). 3426–3426. 4 indexed citations
5.
Cammarata, Giuseppe, Diamante Turri, Valentina Rizzo, et al.. (2007). Gene Expression Profile of Chronic Myeloid Leukemia Innately Resistant to Imatinib. 1(4). 234–242. 3 indexed citations
6.
Turri, Diamante, Matteo Rosselli, Paolo Simioni, et al.. (2001). Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in Mediterranean area. Digestive and Liver Disease. 33(7). 559–562. 22 indexed citations
7.
Quintini, Gerlando, Emilio Iannitto, Vincenzo Bàrbera, et al.. (2001). Response to low-dose oral methotrexate and prednisone in two patients with angio-immunoblastic lymphadenopathy-type T-cell lymphoma. The Hematology Journal. 2(6). 393–395. 12 indexed citations
8.
Turri, Diamante, et al.. (1991). Alpha-interferon in polycythemia vera and essential thrombocythemia.. PubMed. 76(1). 75–7. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026